Search Within

Lisa De Angelis

  1. "CTCR Scholars"
Formats
  1. Meeting Abstract (6)
  2. Journal Article (3)
Groups
  1. CTCR Scholars (9)
  2. Tow Center for Developmental Oncology (TCDO) (9)
  3. Bone Marrow Transplant (8)
  4. Center for Hematologic Malignancies (8)
  5. Department of Medicine (8)
  6. Hematologic Malignancies, Division of (8)

More Groups

People
  1. Michael Scordo (8)
  2. Craig Sauter (7)
  3. Sergio Giralt (7)
  4. Antonio Omuro (4)
  5. Craig Moskowitz (4)
  6. Matthew Matasar (4)

More People

Years
  1. 2024 (1)
  2. 2021 (1)
  3. 2018 (2)
  4. 2017 (2)
  5. 2016 (1)
  6. 2015 (2)
Publications
  1. Biology of Blood and Marrow Transplantation (4)
  2. Blood (3)
  3. Neuro-Oncology (2)
Publishers
  1. Elsevier Inc. (4)
  2. American Society of Hematology (3)
  3. Oxford University Press (2)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020
    Journal Article

    Tringale, K. R.; Scordo, M.; Yahalom, J.; White, C.; Zhang, Z.; Vachha, B.; Cederquist, G.; Schaff, L.; Deangelis, L.; Grommes, C.; more...
    Neuro-Oncology (2024)

    Fulltext@MSK | Save
  • The CDK4/6 inhibitor abemaciclib in patients with recurrent meningioma and other primary CNS tumors
    Meeting Abstract

    Coffee, E.; Panageas, K.; Young, R.; Morrison, T.; Daher, A.; Grommes, C.; Gavrilovic, I. T.; Lin, A.; Miller, A.; Schaff, L.; more...
    Neuro-Oncology (2021)

    Fulltext@MSK | Save
  • Distinctive infectious complications in patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation
    Journal Article

    Scordo, M.; Morjaria, S. M.; Littmann, E. R.; Bhatia, A.; Chung, H. H.; Maloy, M.; DeAngelis, L. M.; Giralt, S. A.; Taur, Y.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Patients with central nervous system lymphoma (CNSL) undergoing thiotepa, busulfan, cyclophosphamide-conditioned autologous stem cell transplantation (TBC-ASCT) are at a higher risk for DNA virus infections than patients receiving traditional conditioning
    Meeting Abstract

    Scordo, M.; Morjaria, S. M.; Bhatia, A.; Littman, E.; Maloy, M.; DeAngelis, L.; Giralt, S. A.; Taur, Y.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Patients with central nervous system lymphoma undergoing thiotepa, busulfan, and cyclophosphamide-conditioned autologous stem cell transplantation are at a higher risk for DNA virus infections than patients with systemic non-Hodgkin lymphoma receiving traditional conditioning
    Meeting Abstract

    Scordo, M.; Morjaria, S. M.; Bhatia, A.; Littmann, E. R.; Maloy, M.; DeAngelis, L.; Giralt, S. A.; Taur, Y.; Sauter, C. S.
    Blood (2017)

    Fulltext@MSK | Save
  • A comprehensive assessment of toxicities in patients with central nervous system lymphoma undergoing autologous stem cell transplantation using thiotepa, busulfan, and cyclophosphamide conditioning
    Journal Article

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L. M.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2017)

    Fulltext@MSK | Save
  • Toxicities and outcomes for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, pharmacokinetically-targeted (PR) busulfan (Bu), cyclophosphamide (TBC) conditioning
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Biology of Blood and Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • A detailed evaluation of transplant-related toxicities and outcome for patients with CNS lymphoma (CNSL) consolidated with high-dose therapy and autologous stem cell transplantation (HDT-ASCT) using thiotepa, busulfan (Bu), cyclophosphamide (TBC) conditioning
    Meeting Abstract

    Scordo, M.; Bhatt, V.; Hsu, M.; Omuro, A. M.; Matasar, M. J.; DeAngelis, L.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; Sauter, C. S.
    Blood (2015)

    Fulltext@MSK | Save
  • Outcomes of pharmacokinetically (PK) directed busulfan in combination with thiotepa & cyclophosphamide (TBC) conditioning with HDT-ASCT in patients with primary & secondary CNS lymphoma
    Meeting Abstract

    Bhatt, V.; Scordo, M.; Hsu, M.; Omuro, A. M.; DeAngelis, L.; Lin, A.; Matasar, M. J.; Dahi, P. B.; Moskowitz, C. H.; Giralt, S. A.; more...
    Blood (2015)

    Fulltext@MSK | Save